Trial Search Results

Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision

This study will examine the feasibility, practicality, utility and usability of a semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit) recently approved by the food and drug administration (FDA) for both Professional (physician office) and over-the-counter (consumer) use. The study seeks to:

1. Assess the correlation of this pregnancy test results with serum values (as distinct from urine) hCG.

2. Assess whether or not time of day of urine collection has any impact on the outcome of the dBest test.

3. Assess user comprehension of the pregnancy test, especially assessment of the result.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Gynuity Health Projects

Stanford Investigator(s):


  • Device: semi-quantitative pregnancy test


Phase 1


Inclusion Criteria:

   - Women 18 years or older, presenting for early abortion, pre-natal care, or fertility

   - If pregnant, gestational age < 84 days by LMP, ultrasound or clinical assessment.

   - Agrees to return for follow-up visit and willing to provide an address and/or
   telephone number for purposes of follow-up.

   - Able to consent to study participation.

Exclusion Criteria:

   - Women less than 18 years of age.

   - Women who are not pregnant, except if presenting for IVF services.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Kelsey Lynd